NCT06379490View on ClinicalTrials.gov

Ultrasound-guided Infraclavicular Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures

PHASE3CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 23, 2024

Primary Completion Date

June 18, 2025

Study Completion Date

June 18, 2025

Conditions
Distal Radius FracturesLidocaineRopivacaineFracture DislocationClosed Reduction of Fracture and Application of Plaster CastColles' Fracture
Interventions
DRUG

Ropivacaine 0.2% Injectable Solution

30 ml of Ropivacaine 0.2% = 60 mg ropivacaine

DRUG

Lidocaine epinephrine

30 ml of Lidocaine 1% with 5 μg/ml epinephrine = 300 mg lidocaine + 150 μg epinephrine

DRUG

Ropivacaine 0.5% Injectable Solution

30 mL of Ropivacaine 0.5% = 150 mg Ropivacaine

Trial Locations (1)

3400

Copenhagen University Hospital - North Zealand, Hillerød

All Listed Sponsors
lead

Nordsjaellands Hospital

OTHER

NCT06379490 - Ultrasound-guided Infraclavicular Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures | Biotech Hunter | Biotech Hunter